Gene Therapy Market 2025 Growth Trends, Share - Global Analysis and Forecasts

Gene Therapy Market to 2025 - Global Analysis and Forecasts by Cell Type (Somatic Gene Therapy, Germline Gene Therapy); By Application (Genetic Disorder, Cancer, Neurological Disorder, and Others)

Report Code: TIPHE100001165 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Gene therapy is introduction of DNA into a patient to treat a genetic disease or a disorder. The newly inserted DNA contains a correcting gene to correct the effects of disease causing mutations. Gene therapy is promising treatment for the genetic diseases and also includes cystic fibrosis and muscular dystrophy. Gene therapy is suitable treatment for the infectious diseases, inherited disease and cancer.

The growth of the gene therapy market is regulated due to various reason which includes the rapid involvement of synthetically modified gene to treat various diseases, it helps in designing the personalized medicine, rise in the research and development of the gene therapy among the others. The gene therapy requires less doses of medicines and is one time treatment, this factor is likely to show growth opportunity for gene therapy market in coming near future.

The "Global Gene Therapy Market Analysis to 2025" is a specialized and in-depth study of the gene therapy industry with a focus on the global market trend. The report aims to provide an overview of global gene therapy market with detailed market segmentation by cell type, application, and geography. The global gene therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

The gene therapy market is segmented based on type as, somatic gene therapy and germline gene therapy. The application segment is classified as genetic disorder, cancer, neurological disorder and others. The cancer segment is expected to grow in coming years as the need of gene correction is must as the gene corrector is introduced to produce a another gene or to inhibit the expression of another gene or to disturb the activity of another gene.

The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global gene therapy market based on cell type, and application. It also provides market size and forecast till 2025 for overall gene therapy market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

North America is anticipated to dominate the gene therapy market in the global scenario owing to various factors such as reimbursement services, technological developments in the biotechnology industry and increasing research activities. Europe is the second largest market for the gene therapy as the various innovation are being done in this region. In 2016, European Union approved Zalmoxis for the treatment of leukemia. Asia Pacific is the fastest growing region as the studies are taking rapid pace for the biotechnological industry and increase in cardiovascular disease.. Owing to these factors the market are likely to propel the growth of the market for gene therapy market in coming future.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key gene therapy manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market Sangamo Therapeutics, Inc., bluebird bio, Inc., uniQure N.V., AveXis, Vineti, Solid Biosciences., Spark Therapeutics, Inc., CHIMERON BIO, RENOVA THERAPEUTICS, and HORAMA S.A.
1 Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance

2 Key Takeaways

3 Gene Therapy Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.2.1 Gene Therapy Market - By Cell Type
3.2.2 Gene Therapy Market - By Application
3.2.3 Gene Therapy Market - By Region
3.3 PEST Analysis
3.3.1 US - PEST Analysis
3.3.2 Europe - PEST Analysis
3.3.3 Asia Pacific - PEST Analysis
3.3.4 Middle East and Africa - PEST Analysis
3.3.5 South and Central America - PEST Analysis

4 Gene Therapy Market - Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis

5 Gene Therapy Market - Global Analysis
5.1 Global Gene Therapy Market Overview
5.2 Global Gene Therapy Market Revenue Forecasts and Analysis (US$ Mn)
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Clinical Trial Analysis
5.6 Expert Opinions

6 Gene Therapy Market Revenue and Forecasts to 2025 - Cell Type (US$ Mn)
6.1 Overview
6.2 Product Market Forecasts and Analysis
6.3 Somatic Gene Therapy Market
6.3.1 Overview
6.3.2 Somatic Gene Therapy Market Revenue Forecasts and Analysis (US$ Mn)
6.4 Germline Gene Therapy Market
6.4.1 Overview
6.4.2 Germline Gene Therapy Market Revenue Forecasts and Analysis (US$ Mn)

7 Gene Therapy Market Revenue and Forecasts to 2025 - Application (US$ Mn)
7.1 Overview
7.2 Application Market Forecasts and Analysis
7.3 Genetic Disorder Market
7.3.1 Overview
7.3.2 Genetic Disorder Market Revenue Forecasts and Analysis (US$ Mn)
7.4 Cancer Market
7.4.1 Overview
7.4.2 Cancer Market Revenue Forecasts and Analysis (US$ Mn)
7.5 Neurological Disorder Market
7.5.1 Overview
7.5.2 Neurological Disorder Market Revenue Forecasts and Analysis (US$ Mn)
7.6 Others Market
7.6.1 Overview
7.6.2 Others Market Revenue Forecasts and Analysis (US$ Mn)

8 North America Gene Therapy Market Revenue and Forecasts to 2025 - Country Analysis
8.1 North America Gene Therapy Market Overview
8.2 North America Gene Therapy Market Revenue Forecasts and Analysis (US$ Mn)
8.3 North America Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
8.4 North America Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)
8.5 North America Market Forecasts and Analysis - By Country
8.6 US Market Overview
8.6.1 US Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
8.6.2 US Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)
8.7 Canada Market Overview
8.7.1 Canada Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
8.7.2 Canada Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)
8.8 Mexico Market Overview
8.8.1 Mexico Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
8.8.2 Mexico Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)

9 Europe Gene Therapy Market Revenue and Forecasts to 2025 - Country Analysis
9.1 Europe Gene Therapy Market Overview
9.2 Europe Gene Therapy Market Revenue Forecasts and Analysis (US$ Mn)
9.3 Europe Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
9.4 Europe Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)
9.5 Europe Market Forecasts and Analysis - By Country
9.6 UK Market Overview
9.6.1 UK Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
9.6.2 UK Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)
9.7 Germany Market Overview
9.7.1 Germany Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
9.7.2 Germany Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)
9.8 France Market Overview
9.8.1 France Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
9.8.2 France Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)

10 Asia Pacific Gene Therapy Market Revenue and Forecasts to 2025 - Country Analysis
10.1 Asia Pacific Gene Therapy Market Overview
10.2 Asia Pacific Gene Therapy Market Revenue Forecasts and Analysis (US$ Mn)
10.3 Asia Pacific Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
10.4 Asia Pacific Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)
10.5 Asia Pacific Market Forecasts and Analysis - By Country
?
10.6 Japan Market Overview
10.6.1 Japan Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
10.6.2 Japan Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)
10.7 China Market Overview
10.7.1 China Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
10.7.2 China Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)
10.8 India Market Overview
10.8.1 India Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
10.8.2 India Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)

11 Middle East & Africa Gene Therapy Market Revenue and Forecasts to 2025 - Country Analysis
11.1 Middle East & Africa Gene Therapy Market Overview
11.2 Middle East & Africa Gene Therapy Market Revenue Forecasts and Analysis (US$ Mn)
11.3 Middle East & Africa Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
11.4 Middle East & Africa Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)
11.5 Middle East & Africa Market Forecasts and Analysis - By Country
11.6 South Africa Market Overview
11.6.1 South Africa Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
11.6.2 South Africa Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)
11.7 Saudi Arabia Market Overview
11.7.1 Saudi Arabia Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
11.7.2 Saudi Arabia Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)
11.8 UAE Market Overview
11.8.1 UAE Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
UAE Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)
?
12 South & Central America Gene Therapy Market Revenue and Forecasts to 2025 - Country Analysis
12.1 South and Central America Gene Therapy Market Overview
12.2 South and Central America Gene Therapy Market Revenue Forecasts and Analysis (US$ Mn)
12.3 South and Central America Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
12.4 South and Central America Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)
12.5 South and Central America Market Forecasts and Analysis - By Country
12.6 Brazil Market Overview
12.6.1 Brazil Gene Therapy Market Forecasts and Analysis - By Cell Type (US$ Mn)
12.6.2 Brazil Gene Therapy Market Forecast and Analysis - By Application (US$ Mn)

13 Industry Landscape
13.1 Organic Growth Strategies
13.1.1 New Product Launches
13.1.2 Marketing & Promotional Activities
13.2 Inorganic Growth Strategies
13.2.1 Partnerships, Collaborations, and Joint Ventures
13.2.2 Mergers & Acquisitions

14 Gene Therapy Market, Key Company Profiles
14.1 Sangamo Therapeutics, Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Financial Overview
14.1.4 Product Portfolio
14.1.5 Product Pipeline
14.1.6 SWOT Analysis
14.1.7 Key Developments

?
14.2 bluebird bio, Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Financial Overview
14.2.4 Product Portfolio
14.2.5 Product Pipeline
14.2.6 SWOT Analysis
14.2.7 Key Developments
14.3 uniQure N.V.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Financial Overview
14.3.4 Product Portfolio
14.3.5 Product Pipeline
14.3.6 SWOT Analysis
14.3.7 Key Developments
14.4 AveXis, Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Financial Overview
14.4.4 Product Portfolio
14.4.5 Product Pipeline
14.4.6 SWOT Analysis
14.4.7 Key Developments
14.5 Vineti
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Financial Overview
14.5.4 Product Portfolio
14.5.5 Product Pipeline
14.5.6 SWOT Analysis
14.5.7 Key Developments

?
14.6 Solid Biosciences.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Financial Overview
14.6.4 Product Portfolio
14.6.5 Product Pipeline
14.6.6 SWOT Analysis
14.6.7 Key Developments
14.7 Spark Therapeutics, Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Financial Overview
14.7.4 Product Portfolio
14.7.5 Product Pipeline
14.7.6 SWOT Analysis
14.7.7 Key Developments
14.8 HORAMA S.A.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Financial Overview
14.8.4 Product Portfolio
14.8.5 Product Pipeline
14.8.6 SWOT Analysis
14.8.7 Key Developments
14.9 RENOVA THERAPEUTICS
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Financial Overview
14.9.4 Product Portfolio
14.9.5 Product Pipeline
14.9.6 SWOT Analysis
14.9.7 Key Developments
?
14.10 CHIMERON BIO
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Financial Overview
14.10.4 Product Portfolio
14.10.5 Product Pipeline
14.10.6 SWOT Analysis
14.10.7 Key Developments

15 Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
15.3 Research Methodology
The List of Companies

1. Sangamo Therapeutics, Inc.
2. bluebird bio, Inc.
3. uniQure N.V.
4. AveXis, Inc.
5. Vineti
6. Solid Biosciences.
7. Spark Therapeutics, Inc.
8. CHIMERON BIO
9. RENOVA THERAPEUTICS
10. HORAMA S.A.

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book